This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
If three sticking points aren’t unstuck soon, older Americans won’t benefit much by the 1,000+ medical devices that, as of 2025, are both equipped with AI and cleared by the FDA.
A new generation of AI-native researchers is leading the way in the war on cancer. This next crop of scientists is AI-native, interdisciplinary—and comfortable challenging assumptions.
The roots of medicine are in the promotion of human welfare, aka humanitarianism. Healthcare AI can either degrade or reinforce this heritage. Who picks the path?
New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.
A primary aim of medical humanities as a field today is teaching medical students how to harmonize technological innovations with care models such that patients are treated as whole persons: They have not just bodies but also minds, relationships—and lives.
Federal lawmakers have a fresh resource to keep them up on healthcare AI that falls outside of formal FDA oversight. It comes in the form of a new report from the nonprofit Bipartisan Policy Center.
Patients who frequently use AI tend to readily trust AI-assisted diagnoses made by their physicians. Counterintuitively, however, those who would rank themselves among the very best-informed about AI tend to mistrust such diagnoses.
The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles in any treatment decisions.